To determine the therapeutic potential of FTO inhibition in an immune-competent HNSCC murine model, we utilized the radiation-resistant MOC2 HPV– HNSCC model (Supplemental Figure 3A). Here, FTO is linked to head and neck squamous cell carcinoma.